A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/28 (2006.01) A61K 9/16 (2006.01) A61K 9/48 (2006.01) A61K 31/19 (2006.01) A61P 25/06 (2006.01)
Patent
CA 2635949
The present invention provides a controlled release dosage formulation comprising a) about 40% to about 80% of a valproic acid compound such as Divalproex Sodium and b) at least two, preferably hydrophilic, polymers each in an amount of less than about 20% of the dosage weight.
La présente invention concerne une forme galénique à libération contrôlée comprenant a) entre environ 40 % et environ 80 % d'un composé d'acide valproïque tel que le Divalproex Sodium et b) au moins deux polymères préférentiellement hydrophiles, chacun une teneur inférieure étant présent en à environ 20 % du poids de la forme galénique.
Ari-Pardo Limor
Shterman Nava
Triger-Messer Yonit
Zilberman Rina
Heenan Blaikie Llp
Teva Pharmaceutical Industries Ltd.
LandOfFree
Controlled release formulation of divalproic acid and its... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release formulation of divalproic acid and its..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release formulation of divalproic acid and its... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2053777